
The FDA will host a series of three town halls to discuss various aspects of the biocompatibility evaluation of medical devices. The series will cover biocompatibility risk assessment approaches with examples, chemical characterization, and toxicological risk assessments.
Town Hall 3: Biocompatibility & Toxicological Risk Assessment
OCTOBER 7, 2026
11:00 AM - 12:00 PM MT
Join In »